FEB 08, 2017 10:30 AM PST

Obtaining non-invasive readouts and early safety signals from rodent models

Speaker
  • Chief Scientific Officer, Vium
    Biography
      Laura Schaevitz has more than 20 years of experience with In vivo animal studies. As Chief Scientific Officer at Vium, she oversees the development of animal models and draws upon her experiences as a molecular and behavioral neuroscientist to direct the application of Vium's digital metrics to the animal models. In past experiences, Laura utilized a broad spectrum of mouse models including transgenic and nutrition-induced models of neurodevelopmental disorders such as autism, schizophrenia, Rett syndrome, and blindsight. Laura received her PhD in Neuroscience at Stanford University in 2006.

    Abstract

    DATE: February 8, 2017
    TIME: 10:30am PT, 1:30pm ET

    The utility of animal models in drug development is limited, in part, by the measures available to researchers for monitoring animals. In life measures are often subjective, lack clinical relevance and can be hard to reproduce.  Conventional approaches to collecting in-life measures are labor-intensive and may introduce experimental variability, as they require frequent handling of the animals during the course of the study.  Vium’s technology platform addresses these essential problems by continuously collecting physiologically relevant data, providing researchers greater insights and consistency for in vivo studies.
     
    We present Vium’s Digital Vivarium, which combines HD video cameras and digital sensors with computer vision and machine learning to enable automatic, continuous assessment of disease progression for study animals simultaneously in the home cage.  The system measures physiologic, behavioral, environmental, husbandry-related, and disease-specific parameters.  Within specific animal models, novel metrics are identified that track disease severity and efficacy of reference compounds automatically and objectively.
     
    We have applied this method across a spectrum of disease models.  This presentation will show how novel Vium metrics can be used to assess disease in a model of lung injury and in the MRL/lpr model of Systemic Lupus Erythematosus. The result is a new paradigm for profiling the safety and efficacy of pharmacological agents that is not limited in scale and throughput by individual technicians.
     
    Learning Objectives:

    • Describe the Vium Platform and demonstrate how novel insights can be derived from non-invasive digital metrics in preclinical rodent studies
    • Continuous digital readouts of physiologic parameters provide reproducible, previously unattainable tracking of disease in Lupus and Lung Injury models as examples.
       

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    DEC 16, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 16, 2020 8:00 AM PST
    Date: December 16, 2020 Time: 8:00am (PST), 11:00am (EST) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data to better under...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    FEB 08, 2017 10:30 AM PST

    Obtaining non-invasive readouts and early safety signals from rodent models


    Specialty

    Animal Models

    Animal Research

    Animal Sciences

    Research And Development

    Animal Behavior

    Immunology

    Animals

    Life Science

    Protein

    Research

    Biomarkers

    Molecular Biology

    Health

    T-Cells

    Allergy

    Geography

    Europe82%

    North America6%

    Registration Source

    Website Visitors100%

    Job Title

    Scientist31%

    Medical Laboratory Technician23%

    Research Scientist23%

    Medical Doctor/Specialist8%

    Animal Care Lab Technician8%

    Post Doc8%

    Organization

    Academic Institution35%

    Research Institute18%

    Pharmaceutical Company18%

    Industrial Company6%

    Clinical Laboratory6%

    Hospital6%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more